Biological activity of 5-aminolevulinic acid and its methyl ester after storage under different conditions

Journal of Photochemistry and Photobiology B: Biology

Volumn 87, Issue 2, 2007, Pages 67-72

  Kaliszewski, Miron ^a,b   Kwasny, Miroslaw ^b   Juzeniene, Asta ^a   Juzenas, Petras ^a   Graczyk, Alfreda ^b   Ma, Li Wei ^a   Iani, Vladimir ^a   Mikolajewska, Patrycja ^a   Moan, Johan ^a,c  

^a INSTITUTE OF CANCER RESEARCH   (Norway)

^b MILITARY UNIVERSITY OF TECHNOLOGY   (Poland)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

5 Aminolevulinic acid; ALA esters; Photodynamic therapy; Protoporphyrin IX; Stability

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; HEME; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ASSAY; CELL SURVIVAL; CELL VIABILITY; COLON ADENOCARCINOMA; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIMERIZATION; DRUG ACTIVITY; DRUG STABILITY; DRUG STORAGE; FEMALE; HIGH TEMPERATURE; HUMAN; HUMAN CELL; LOW TEMPERATURE; MOUSE; NONHUMAN; PH; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STORAGE TEMPERATURE;

AMINOLEVULINIC ACID; DRUG STABILITY; ESTERS; HYDROGEN-ION CONCENTRATION; KINETICS; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; TEMPERATURE;

EID: 34248214722     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2007.01.003     Document Type: Article

References (21)

1. Di Venosa G., Fukuda H., Perotti C., Batlle A., and Casas A. A method for separating ALA from ALA derivatives using ionic exchange extraction. J. Photochem. Photobiol. B 75 3 (2004) 157-163
2. Grönlund-Pakkanen S., Wahlfors J., Talja M., Kosma V.-M., Pakkanen T.M., Ala-Opas M., Alhava E., and Moore R.B. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma. BJU Int. 92 1 (2003) 125-130
3. Ziolkowski P., Osiecka B.J., Oremek G., Siewinski M., Symonowicz K., Saleh Y., and Bronowicz A. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. J. Exp. Ther. Oncol. 4 2 (2004) 121-129
4. Casas A., and Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr. Med. Chem. Anticancer Agents 2 4 (2002) 465-475
5. Kaliszewski M., Juzeniene A., Juzenas P., Kwasny M., Kaminski J., Dabrowski Z., Golinski J., and Moan J. Formation of protoporphyrin IX from carboxylic- and amino-derivatives of 5-aminolevulinic acid. Photodiagn. Photodyn. Ther. 2 2 (2005) 129-134
6. Kloek J., and Beijersbergen van Henegouwen G.M.J. Prodrugs of 5-Aminolevulinic Acid for Photodynamic Therapy. Photochem. Photobiol. 64 6 (1996) 994-1000
7. Kaliszewski M., Kwasny M., Kaminski J., Dabrowski Z., and Burdziakowska E. The stability of 5-aminolevulinic acid and its ester derivatives. Acta Pol. Pharm. 61 1 (2004) 15-19
8. Bunke A., Zerbe O., Schmid H., Burmeister G., Merkle H.P., and Gander B. Degradation mechanism and stability of 5-aminolevulinic acid. J. Pharm. Sci. 89 10 (2000) 1335-1341
9. de Blois A.W., Grouls R.J.E., Ackerman E.W., and Wijdeven W.J.A. Development of a stable solution of 5-aminolevulinic acid for intracutaneous injection in photodynamic therapy. Lasers Med. Sci. 17 (2002) 208-215
10. McCarron P.A., Donnelly R.F., Andrews G.P., and Woolfson A.D. Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application. J. Pharm. Sci. 94 8 (2005) 1756-1771
11. Novo M., Huttmann G., and Diddens H. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. J. Photochem. Photobiol. B 34 2-3 (1996) 143-148
12. Elfsson B., Wallin I., Eksborg S., Rudaeus K., Ros A.M., and Ehrsson H. Stability of 5-aminolevulinic acid in aqueous solution. Eur. J. Pharm. Sci. 7 2 (1999) 87-91
13. Hunter G.A., Rivera E., and Ferreira G.C. Supraphysiological concentrations of 5-aminolevulinic acid dimerize in solution to produce superoxide radical anions via a protonated dihydropyrazine intermediate. Arch. Biochem. Biophys. 437 2 (2005) 128-137
14. McCarron P.A., Donnelly R.F., Woolfson A.D., and Andrews G.P. Analyzis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: Methodology and assay validation. J. Pharm. Biomed. Anal. 36 (2005) 1099-1105
15. Auner B.G., Petzenhauser E., and Valenta C. Influence of 6-Ketocholestanol on Skin Permeation of 5-Aminolevulinic Acid and Evaluation of Chemical Stability. J. Pharm. Sci. 93 (2004) 2780-2787
16. Gadmar Ø.B., Moan J., Scheie E., Ma L.-W., and Peng Q. The stability of 5-aminolevulinic acid in solution. J. Photochem. Photobiol. B 67 (2002) 187-193
17. Noguchi P., Wallace R., Johnson J., Earley E.M., O'Brien S., Ferrone S., Pellegrino M.A., Milstein J., Needy C., Browne W., and Petricciani J. Characterization of WiDr: a human colon carcinoma cell line. In vitro 15 (1979) 401-408
18. Juzeniene A., Ma L.W., Juzenas P., Iani V., Lange N., and Moan J. Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissue in vivo. Cell. Mol. Biol. 48 8 (2002) 911-916
19. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Meth. 89 (1986) 271-277
20. Juzeniene A., Juzenas P., Iani V., and Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and oxylester derivatives: considerations for dosimetry in mouse skin model. Photochem. Photobiol. 76 (2002) 329-334
21. Di Venosa G., Batlle A., Fukuda H., MacRobert A., and Casas A. Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues. Cancer Chemother. Pharmacol. 58 (2006) 478-486